Collaborations

Share

Our pipeline include antibodies addressing two receptors, progressing into pre clinical stage:

Immune Oncology

Clinical Indications:
Metastatic melanoma

Immune Oncology

Clinical Indications:
Metastatic melanoma, Metastatic lung cancer

Immune Oncology

Immune Oncology

Immune Oncology

Tikcro develops its drug candidates in collaboration with research centers and pharmaceutical contracting partners.

Our strategy is to establish product development, pre clinical and discovery collaborations. These collaborations supplement our corporate and business capabilities, to advance our pipeline and validate our technology.

Product in Development

Initiated

CTLA-4 Antibody for immune oncology
PD1 Antibody for immune oncology

December 2014

© Copyright 2015, Tikcro Ltd. | Legal - Terms of use | All rights reserved | Site by Imaginet